Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 06/18/2026 | CALL | $7.50 | 283 | +7 | +2.54% |
| 01/15/2027 | PUT | $7.50 | 7 | +4 | +133.33% |
| 12/17/2027 | PUT | $7.50 | 2 | +2 | |
| 06/18/2026 | CALL | $10.00 | 14 | +1 | +7.69% |
| 06/18/2026 | CALL | $2.50 | 0 | 0 | |
| 06/18/2026 | CALL | $5.00 | 0 | 0 | |
| 12/17/2027 | PUT | $5.00 | 0 | 0 | |
| 12/17/2027 | PUT | $10.00 | 0 | 0 | |
| 12/17/2027 | PUT | $12.50 | 0 | 0 | |
| 12/17/2027 | PUT | $15.00 | 0 | 0 | |
| 12/17/2027 | PUT | $17.50 | 0 | 0 | |
| 01/15/2027 | CALL | $20.00 | 751 | -2 | -0.27% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Presbyopia Market to Witness Accelerated Growth at a CAGR of 4.9% During the Forecast Period (2026–2036) Supported by Expanding Treatment Landscape | DelveInsight
05/11 01:00 pm
GlobeNewswire Inc.
Read moreWhy Lenz Therapeutics Stock Crashed Today
03/24 10:13 am
The Motley Fool
Read moreLenz (LENZ) Q2 Revenue Jumps 604%
07/31 09:10 am
The Motley Fool
Read moreLENZ Therapeutics to Host Key Opinion Leader Event on June 18, 2024
06/10 08:00 am
GlobeNewswire Inc.
Read moreLENZ Therapeutics to Present at the Jefferies Global Healthcare Conference
05/30 08:00 am
GlobeNewswire Inc.
Read moreLENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
05/08 04:01 pm
GlobeNewswire Inc.
Read moreLENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024
05/01 04:01 pm
GlobeNewswire Inc.
Read moreBlindness-Focused LENZ Therapeutics' Investigational Eye Drop Ready To Revolutionize Presbyopia Landscape, Analyst Says
04/10 03:19 pm
Benzinga
Read more